Clinical Trial Update: A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing belotecan to topotecan as monotherapy in sensitive-relapsed small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Belotecan (Belotecan)
• Topotecan (topotecan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED